|
|
Aw: Was ist eigentlich aus Follica geworden? [Beitrag #196764 ist eine Antwort auf Beitrag #196744] :: Mo., 20 Dezember 2010 18:58
|
|
schreib halt ne mail an follicia....
(Updated--6:15 pm ET, 6/01/10) Follica has raised more money for its quest against hair follicle disorders like male pattern baldness. The biotech startup, which is developing drugs that could spur the formation of new hair follicles, has raised $7.5 million in equity financing, according to an SEC filing.
Daphne Zohar, a Follica co-founder and managing director at PureTech Ventures in Boston, says the funding mentioned in the SEC filing is part of the startup's Series B round of funding. The new cash came from Follica's previous backers, which include PureTech, InterWest Partners, of Menlo Park, CA, and Waltham, MA-based Polaris Venture Partners. The Series B round was initially announced as an $11 million financing back in 2008, but Zohar says that was not the actual amount raised at the time and this latest infusion of capital brings the total round to $13 million. (Editor's note: this paragraph was changed from the originally published version to include additional details from Zohar about the total amount raised in Follica's second round of financing.)
"The investors are pleased," Zohar said. "Things are going really well--it's really exciting."
Exactly how much progress Follica has made in developing a new hair-loss therapy, or whether baldness is the number-one target in its pipeline, Zohar wouldn't say. The policy of the firm, she said, has been not to comment in detail on R&D activities. (Here's an update on the firm's status that Xconomy posted back in January.)
I did learn from Zohar that the company's headquarters are now in Mendham, NJ, and have been since drug industry veteran William Ju took over as the firm's CEO last year. Yet the firm continues to conduct drug-delivery and device research as well as corporate development in Boston, she said. Ju was not immediately available for comment this afternoon.
Unfortunately, this funding news doesn't provide any new clues about whether Follica is much closer to bringing to market a treatment for baldness. Judging from the frenzy of interest in our previous Follica posts, it's clear that many people are excited about the firm's approach of generating new follicles to grow shoots of hair. Its technology, which is licensed from the University of Pennsylvania, could also be used to deliver permanent removal of unwanted hair.
If anything, we could hold out hope that more money for Follica means it has a greater chance of advancing its much-anticipated treatments for hair loss.
Die letzten News von Mitte 2010, also noch nicht so lange her..
Genrell kann wohl niemand sagen wo sie aktuell stehen ob sie klinische studien machen etc.
follicia ist da sehr verschlossen, aber schreib mal ne mail hin..
|
Den Beitrag einem Moderator melden
|
|
|
|
|
|
Aw: Was ist eigentlich aus Follica geworden? [Beitrag #196806 ist eine Antwort auf Beitrag #196805] :: Di., 21 Dezember 2010 10:30
|
jochenknochen
Beiträge: 335 Registriert: September 2009 Ort: Niedersachsen
|
imsommernw0 schrieb am Tue, 21 December 2010 09:56Thanks for your interest in Follica.
Our publically shared information can be found on our website. We are committed to driving this technology forward and are enthusiastic about
the potential. With that said, developing a new treatment takes time and we appreciate your patience as we progress in a diligent manner.
Your support is very important to us and encourages us to move forward as quickly as possible.
Sincerely,
The Follica Team
hört sich nach nicht viel an ;(
|
Den Beitrag einem Moderator melden
|
|
|
|
|
|
|
|
Aw: Was ist eigentlich aus Follica geworden? [Beitrag #196826 ist eine Antwort auf Beitrag #196811] :: Di., 21 Dezember 2010 17:03
|
HirschGeweih
Beiträge: 2388 Registriert: Dezember 2009 Ort: berlin
|
Schneeball schrieb am Tue, 21 December 2010 13:36Es hiess immmer,das alle medikament,welch sie benutzen...alle fda erprobt sind....
brauchen sie ja auch alle, man kann ja schlecht was am menschen testen ohne vorherr eine offiziele genehmigung zu haben.
kein minox mehr aufgrund von hefepilz
Fincar - 1 X 1,25mg
Zink-Chelat 2x 50mg
Beta Sitosterol 2x 375mg
Ket 2% - 1x am tag
wegen eisenanämie eisen-2-glycin sulphat 1x sonnenstudio und bifonazol creme gegen hefepilz
|
Den Beitrag einem Moderator melden
|
|
|
|
|